| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT07200089 Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA… |
Recruitment opened |
| 2026-06-11 | NCT07200089 Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA… |
date change Completion pushed: 2028-11-30 -> 2028-12-31 |
| 2026-06-11 | NCT07313592 Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients |
Recruitment opened |
| 2026-06-11 | NCT07313592 Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients |
date change Primary completion pushed: 2028-06-15 -> 2028-07-15 |
| 2026-06-11 | NCT07313592 Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients |
date change Completion pushed: 2028-06-15 -> 2028-07-15 |
| 2026-06-10 | NCT07039760 Asciminib With or Without Sildenafil for Brain Tumors |
date change Primary completion pushed: 2027-10-31 -> 2028-02-28 |
| 2026-06-10 | NCT07039760 Asciminib With or Without Sildenafil for Brain Tumors |
date change Completion pushed: 2027-11-30 -> 2028-03-31 |
| 2026-06-10 | NCT06367465 Feasibility and Acceptability of HCV Treatment in Pregnancy |
date change Primary completion pushed: 2026-02-28 -> 2026-12-28 |
| 2026-06-10 | NCT06367465 Feasibility and Acceptability of HCV Treatment in Pregnancy |
date change Completion pushed: 2026-02-28 -> 2026-12-28 |
| 2026-06-10 | NCT06397989 Peanut-based School Meals in Rural Ghana to Improve Attendance and Retention |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-10 | NCT06397989 Peanut-based School Meals in Rural Ghana to Improve Attendance and Retention |
Enrollment reduced: 6700 -> 5800 participants |
| 2026-06-10 | NCT06397989 Peanut-based School Meals in Rural Ghana to Improve Attendance and Retention |
date change Primary completion moved earlier: 2026-11 -> 2026-07 |
| 2026-06-10 | NCT06397989 Peanut-based School Meals in Rural Ghana to Improve Attendance and Retention |
date change Completion moved earlier: 2026-11 -> 2026-07 |
| 2026-06-09 | NCT07200102 Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma |
Primary endpoint(s) modified |
| 2026-06-05 | NCT06399679 Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium |
Recruitment suspended |
| 2026-06-05 | NCT06399679 Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium |
critical why stopped: null → "Physostigmine (standard of care treatment under this protocol) became unavailable at the study site June 1st 2026, requiring suspension of the study." |
| 2026-06-05 | NCT06399679 Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium |
date change Primary completion pushed: 2026-10 -> 2028-11 |
| 2026-06-05 | NCT06399679 Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium |
date change Completion pushed: 2026-11 -> 2028-12 |
| 2026-06-04 | NCT06639607 PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and… |
date change Primary completion pushed: 2031-06-30 -> 2031-08-31 |
| 2026-06-04 | NCT06639607 PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and… |
date change Completion pushed: 2043-04-30 -> 2051-06-30 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-04 | NCT07625098 Feasibility of SUPPORT-TBI | Phase 1 | Not Yet Recruiting |
| 2026-06-02 | NCT07619365 Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic… | Phase 2 | Not Yet Recruiting |
| 2026-06-02 | NCT07620548 Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in… | Phase 2 | Not Yet Recruiting |
| 2026-06-01 | NCT07617363 ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk… | Phase 1 | Not Yet Recruiting |
| 2026-05-18 | NCT07593079 Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and… | Phase 2 | Not Yet Recruiting |
| 2026-05-15 | NCT07589387 Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07241117 | CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma | Moderate to Severe Asthma | Recruiting |
| NCT07280195 | ZYNRELEF vs Continuous Catheter for Pain Management Following Shoulder Arthroplasty | Total Shoulder Arthroplasty | Enrolling by Invitation |
| NCT07493460 | Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines | Immunology | Active, Not Recruiting |
| Phase 3 | |||
| NCT06969287 | Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery | Delirium | Recruiting |
| NCT04966481 | Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered… | HPV-unrelated Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT06384573 | DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease | Alzheimer's Disease | Active, Not Recruiting |
| NCT02181257 | Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts | Bronchiolitis Obliterans Syndrome (BOS) | Active, Not Recruiting |
| NCT07569640 | HFrEF Polypill in Sri Lanka RCT | Heart Failure With Reduced Ejection Fraction | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT05552157 | A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a… | Alzheimers Disease | Recruiting |
| NCT06647498 | A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a… | Alzheimers Disease | Recruiting |
| NCT01760005 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study… | Alzheimers Disease | Active, Not Recruiting |
| NCT05269394 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study… | Alzheimers Disease | Active, Not Recruiting |
| Phase 2 | |||
| NCT06559540 | Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer | Node-positive Breast Cancer | Recruiting |
| NCT05903131 | Uterine Preservation Via Lifestyle Transformation | Endometrial Hyperplasia | Recruiting |
| NCT06429501 | Local Anesthesia for Facial Fractures | Pain Management | Recruiting |
| NCT07092514 | Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive… | Thyroid Cancer | Recruiting |
| NCT06687772 | CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based… | Diffuse Large B Cell Lymphoma | Recruiting |
| NCT06445166 | Propranolol for the Treatment of Kaposi Sarcoma in Adults | Kaposi Sarcoma | Recruiting |
| NCT05483010 | Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and… | Clonal Cytopenia of Undetermined Significance | Recruiting |
| NCT05837455 | NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With… | Breast Cancer | Recruiting |
| NCT06483100 | Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance | Multiple Myeloma | Recruiting |
| NCT07126158 | Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic… | Pancreatic Adenocarcinoma | Recruiting |
| NCT07462507 | Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using… | Central Nervous System Cancer | Recruiting |
| NCT07419464 | 5-Fluorouracil Response and Optimization STudy (The FROST Trial) | Squamous Cell Carcinoma of Head and Neck | Recruiting |
| NCT04852328 | Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation… | Oropharyngeal Squamous Cell Carcinoma | Recruiting |